A

Anchiano Therapeutics

2 employees

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
Health Care
Gene Therapy
RAS
immunotherapy
Pan-RAS
Oncology
Bladder Cancer
Target Therapy
Cancer

Date founded

2004

Funding rounds raised

Total raised

$23M

from 2 investors over 2 rounds

A

Anchiano Therapeutics raised $23M on April 13, 2018

Investors: Clal Biotechnology Industries

A

Anchiano Therapeutics raised undisclosed on March 1, 2010

Investors: Cybele Holdings

FAQ